Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

223610

registered interest
date	25/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Monosodium Glutamate
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what representations his Department has received on the long-term effects on health of monosodium glutamate in food.
tabling member constituency	Bristol North West
tabling member printed	Charlotte Leslie
uin	225437
answer	answer is ministerial correction date of answer 02/03/2015 answer text <p>We are advised by the Food Standards Agency, which has responsibility for food safety, that they occasionally receive questions from members of the public and other interested parties about monosodium glutamate (MSG).</p><p> </p><p> </p><p> </p><p>All food additives, including MSG, are only permitted after a safety evaluation and the legislation sets out the foods in which it can be used and the conditions of use. MSG has been reviewed by a number of independent expert committees at United Kingdom, European and international level. These committees have concluded that at current levels of use MSG does not present a risk to health.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 02/03/2015 17:27:02 answering member 3918 label Biography information for Jane Ellison
tabling member	3933 label Biography information for Charlotte Leslie

223623

registered interest
date	25/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Gambling
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what data his Department holds on and what assessment it has made of the effects of gambling on mental health; and how much his Department spent on counselling for people with an addiction to gambling in the last 12 months.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	225496
answer	answer is ministerial correction date of answer 02/03/2015 answer text <p>My Rt. hon. Friend the Secretary of State for Health and his officials have had no discussions with other Government departments on the subject of a national gambling strategy.</p><p> </p><p> </p><p> </p><p>The Department has not made an assessment of the effects of gambling on mental health. We do not centrally hold information on the amount spent on counselling for people with a gambling addiction in the last 12 months.</p><p> </p><p> </p><p> </p><p>This Government has invested over £400 million in the Improving Access to Psychological Therapy programme over the spending review period to make a choice of psychological therapies available for those who need them in all parts of England. This includes people who experience mental ill health as a result of an addiction to gambling.</p><p> </p><p> </p><p> </p><p><em>Achieving Better Access to Mental Health Services by 2020,</em> published in October 2014, articulates our ambition and the immediate actions we are taking to achieve better access and waiting times in mental health services. It includes the Improving Access to Psychological Therapies commitment of treatment within six weeks for 75% of people with 95% of people being treated within 18 weeks.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 225488 question first answered 02/03/2015 17:42:51 answering member 1439 label Biography information for Norman Lamb
tabling member	4036 label Biography information for Luciana Berger

223624

registered interest
date	25/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Patients: Transport
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many contracts Arriva holds for patient transport services; and what area each such contract covers.
tabling member constituency	Leicester West
tabling member printed	Liz Kendall
uin	225482
answer	answer is ministerial correction date of answer 02/03/2015 answer text <p>This information is not held centrally.</p><p> </p><p> </p><p> </p><p>Patient transport services (PTS) are commissioned by clinical commissioning groups (CCGs). A range of different providers may provide PTS - for example, the local NHS ambulance trust, independent sector providers, or a combination of providers.</p><p> </p><p> </p><p> </p><p>Decisions about patient transport services are a local matter and it remains up to CCGs to decide how these services are managed. It is important that CCGs have the flexibility to provide and tailor patient transport service provision for their registered population.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 02/03/2015 17:46:34 answering member 3918 label Biography information for Jane Ellison
tabling member	4026 label Biography information for Liz Kendall

223629

registered interest
date	25/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Asthma
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 28 October 2014 to Question 211702, how many finished hospital admission episodes with a primary diagnosis of asthma there were among people aged (a) under and (b) over 18 years in 2013-14.
tabling member constituency	Leicester West
tabling member printed	Liz Kendall
uin	225498
answer	answer is ministerial correction date of answer 02/03/2015 answer text <p>The table below provides a count of finished admission episodes (FAEs) with a primary diagnosis of asthma by age for the year 2013-14.</p><p> </p><p><strong> </strong></p><p> </p><table><tbody><tr><td><p>Age</p></td><td><p>FAEs</p></td></tr><tr><td><p>0-17</p></td><td><p>25,841</p></td></tr><tr><td><p>18+</p></td><td><p>39,916</p></td></tr><tr><td><p>Unknown</p></td><td><p>97</p></td></tr></tbody></table><p> </p><p><strong> </strong></p><p> </p><p><em>Notes: </em></p><p> </p><ol start="1" type="1"><li>An FAE is the first period of inpatient care under one consultant within one healthcare provider. FAEs are counted against the year or month in which the admission episode finishes. Admissions do not represent the number of inpatients, as a person may have more than one admission within the period.</li><li>The primary diagnosis is the first of up to 20 (14 from 2002-03 to 2006-07 and 7 prior to 2002-03) diagnosis fields in the Hospital Episode Statistics data set and provides the main reason why the patient was admitted to hospital.</li></ol><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 02/03/2015 17:47:51 answering member 3918 label Biography information for Jane Ellison
tabling member	4026 label Biography information for Liz Kendall

223630

registered interest
date	25/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Care Homes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 1 July 2014 to Question 202551, how many residents of care homes had an emergency admission to a hospital in 2013-14.
tabling member constituency	Leicester West
tabling member printed	Liz Kendall
uin	225499
answer	answer is ministerial correction date of answer 02/03/2015 answer text <p>Information on the number of emergency admissions from care homes to a hospital in 2013-14 is shown in the following table, alongside the total number of emergency admissions.</p><p> </p><p>Number of finished admission episodes for emergency admissions by source of admission in England, 2013-14</p><p> </p><table><tbody><tr><td><p>Source of admission</p></td><td><p>2013-14</p></td></tr><tr><td><p>NHS run care home (from 1 April 2004)</p></td><td><p>3,541</p></td></tr><tr><td><p>Non-NHS (other than local authority) run care home</p></td><td><p>16,037</p></td></tr><tr><td><p>All sources of admission</p></td><td><p>5,415,462</p></td></tr></tbody></table><p> </p><p><em>Source:</em></p><p> </p><p>Hospital Episode Statistics (HES), Health and Social Care Information Centre</p><p> </p><p><em> </em></p><p> </p><p><em>Notes:</em></p><p> </p><p>1. Includes activity in English National Health Service hospitals and English NHS commissioned activity in the independent sector.</p><p> </p><p>2. A finished admission episode (FAE) is the first period of admitted patient care under one consultant within one healthcare provider. FAEs are counted against the year or month in which the admission episode finishes. Admissions do not represent the number of patients, as a person may have more than one admission within the period.</p><p> </p><p>3. Changes to the figures over time need to be interpreted in the context of improvements in data quality and coverage (particularly in earlier years), improvements in coverage of independent sector activity (particularly from 2006-07) and changes in NHS practice.</p><p> </p><p>4. FAEs recorded as &quot;The usual place of residence, including no fixed abode&quot; may contain a number of episodes where patients may have resided in care homes, subsequently designating it as their usual place of residence. Consequently, these episodes were not recorded as admissions from a care home. The number of times this may have occurred is unknown.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 02/03/2015 17:45:27 answering member 1439 label Biography information for Norman Lamb
tabling member	4026 label Biography information for Liz Kendall

223631

registered interest
date	25/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Gambling
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions he and officials in his Department have had with their counterparts in other Departments on a national gambling strategy.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	225488
answer	answer is ministerial correction date of answer 02/03/2015 answer text <p>My Rt. hon. Friend the Secretary of State for Health and his officials have had no discussions with other Government departments on the subject of a national gambling strategy.</p><p> </p><p> </p><p> </p><p>The Department has not made an assessment of the effects of gambling on mental health. We do not centrally hold information on the amount spent on counselling for people with a gambling addiction in the last 12 months.</p><p> </p><p> </p><p> </p><p>This Government has invested over £400 million in the Improving Access to Psychological Therapy programme over the spending review period to make a choice of psychological therapies available for those who need them in all parts of England. This includes people who experience mental ill health as a result of an addiction to gambling.</p><p> </p><p> </p><p> </p><p><em>Achieving Better Access to Mental Health Services by 2020,</em> published in October 2014, articulates our ambition and the immediate actions we are taking to achieve better access and waiting times in mental health services. It includes the Improving Access to Psychological Therapies commitment of treatment within six weeks for 75% of people with 95% of people being treated within 18 weeks.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 225496 question first answered 02/03/2015 17:42:51 answering member 1439 label Biography information for Norman Lamb
tabling member	4036 label Biography information for Luciana Berger

223635

registered interest
date	25/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Muscular Dystrophy: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if the Minister for Life Sciences will hold a further meeting with families of people with Duchenne muscular dystrophy on the availability of the drug Translarna.
tabling member constituency	Chesham and Amersham
tabling member printed	Mrs Cheryl Gillan
uin	225407
answer	answer is ministerial correction date of answer 02/03/2015 answer text <p>I have had a number of meetings with patients and their families, hon. Members, charities and patient groups and I am keeping in close contact via correspondence with families and campaigners on this issue and on the availability of another drug, Vimizim for the treatment of Morquio syndrome. Whilst the key decisions are for the National Institute for Health and Care Excellence (NICE) and NHS England, I have also met with the manufacturers and NHS England and had discussions with NICE about ensuring as rapid a decision as possible and I am doing all I can to help those affected and get a swift resolution to this situation.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 02/03/2015 17:44:25 answering member 4020 label Biography information for George Freeman
tabling member	18 label Biography information for Dame Cheryl Gillan

223644

registered interest
date	25/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Anticoagulants
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the reasons for the difference in the up-take of novel oral anticoagulants and the uptake projected by NICE.
tabling member constituency	Chesham and Amersham
tabling member printed	Mrs Cheryl Gillan
uin	225341
answer	answer is ministerial correction date of answer 02/03/2015 answer text <p>Decisions on the prescribing of medicines are a matter for clinicians with their patients.</p><p> </p><p> </p><p> </p><p>National Health Service commissioners are legally required by regulations to fund those anticoagulant treatments recommended by the National Institute for Health and Care Excellence (NICE) in its technology appraisal guidance.</p><p> </p><p> </p><p> </p><p>The NICE Implementation Collaborative has been established to support faster and more consistent access to NICE recommended medicines, treatments and technologies. The NICE Implementation Collaborative published a consensus statement on supporting the use of novel oral anticoagulants (NOACs) in non-valvular atrial fibrillation on 18 June 2014. The statement includes an analysis of the barriers to the use of NOACs. This is available at:</p><p> </p><p> </p><p> </p><p>www.nice.org.uk/resource/CG180/pdf/c/cg180-atrial-fibrillation-nic-consensus-statement-on-the-use-of-noacs?id=gvyb3hjdqrcjtn6ytpwx3ydb64</p><p> </p><p> </p><p> </p><p>NICE published its updated clinical guideline of the management of atrial fibrillation on 26 June 2014 which recommends that novel oral anticoagulants should be offered where appropriate. The latest data from the Innovation Scorecard show that uptake of the new anticoagulants across England is increasing.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 02/03/2015 17:45:46 answering member 4020 label Biography information for George Freeman
tabling member	18 label Biography information for Dame Cheryl Gillan

223645

registered interest
date	25/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	IVF: West Midlands
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what estimate he has made of the number of IVF cycle procedures that were carried out by each West Midlands NHS trust in the most recent year for which figures are available.
tabling member constituency	Dudley North
tabling member printed	Ian Austin
uin	225304
answer	answer is ministerial correction date of answer 02/03/2015 answer text <p>No such estimates have been made.</p><p> </p><p> </p><p> </p><p>The sum of finished consultant episodes (FCE) with a main or secondary procedure of (a) IVF cycle procedures, (b) cataract surgery procedures, (c) hip replacement operations, (d) knee replacement operations, (e) varicose vein surgery procedures and (f) breast reconstruction operations carried out by West Midlands NHS Trusts in 2013/14 is shown in the attached table.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 225313 225315 225316 225317 225318 question first answered 02/03/2015 17:39:12 answering member 3918 label Biography information for Jane Ellison attachment 1 file name FCEs by West Midlands NHS Trust in 2013-14.docx title FCEs by West Midlands NHS Trust in 2013-14
tabling member	1511 label Biography information for Lord Austin of Dudley

223646

registered interest
date	25/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps NICE and NHS England take to ensure that (a) mandatory NICE health technology assessment guidance is fully implemented by clinical commissioning groups and (b) the up-take of innovative medicines is in line with NICE's expectations.
tabling member constituency	Chesham and Amersham
tabling member printed	Mrs Cheryl Gillan
uin	225342
answer	answer is ministerial correction date of answer 02/03/2015 answer text <p>National Health Service commissioners are legally required to fund drugs and treatments recommended by technology appraisal guidance issued by the National Institute for Health and Care Excellence (NICE) within three months of the publication of final guidance. NICE offers a range of resources to support implementation of its technology appraisal guidance at a local level that are tailored to each topic and may include resource impact assessments and clinical audit tools. NICE also employs a team of implementation consultants who work with the NHS to help to put NICE’s guidance into practice. NICE also provides the secretariat for the NICE Implementation Collaborative that is a partnership between NICE, the NHS, industry and patient groups and seeks to identify and remove barriers to implementation of NICE’s guidance. NICE is not, however, a regulator and has no remit to enforce implementation of its guidance.</p><p> </p><p> </p><p> </p><p>We are working closely with NHS England, industry and other key stakeholders to improve the Innovation Scorecard to make it a more effective tool for identifying unjustified variation in uptake of innovative treatments in the NHS. The data from the Scorecard supports conversations between NHS England and regional/local NHS organisations about patterns of uptake across England, and for some products includes estimates of expected uptake developed by NICE on the basis of their guidance<em>.</em></p><p> </p><p> </p><p> </p><p>In addition, the Government takes the issue of ensuring rapid access to innovative therapies very seriously, which is why I have launched a major review of the pathways for the development, assessment, and adoption of innovative medicines and medical technology. This review will consider how to speed up access for NHS patients to cost-effective new diagnostics, medicines and devices, including cancer treatments and diagnostics. It will set out both short and long-term options for action by Government and relevant bodies, including NICE, the Medicines and Healthcare products Regulatory Agency and NHS England, to accelerate access for NHS patients to innovative medicines.</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 02/03/2015 17:24:39 answering member 4020 label Biography information for George Freeman
tabling member	18 label Biography information for Dame Cheryl Gillan